Oncology Clinical Scientist: Data-Driven Cancer Trials

Syneos Health/ inVentiv Health Commercial LLC; New Orleans (LA); On-site; USD 110,000 - 160,000; Full time

Benefits offered by this job

Company car or car allowance

Health benefits (Medical, Dental, VIs)

401k

Employee Stock Purchase Plan

Bonus/commissions

Flexible PTO and sick time

Job summary

Syneos Health is seeking a Clinical Scientist - Oncology to collaborate with Medical Directors and study teams on medical data reviews and plans. The role focuses on data-driven decision making, rigorous interpretation of listings and visualizations, and contributing to safety assessments across oncology programs.

The position emphasizes partnership with internal and external stakeholders, adherence to ICH/GCP, and involvement in audits and process improvements to accelerate therapy delivery.

Qualifications

• Hands-on experience in medical data review and data pattern analysis.
• Ability to coordinate with medical directors and external experts.
• Strong scientific writing and data visualization capabilities.

Responsibilities

• Develop medical plans with Medical Director and coordinate input from experts.
• Perform regular/ad-hoc medical data review of data listings and visuals, identify risks.
• Author medical data queries and manage query responses with Medical Director.
• Assist in patient profiles review and protocol deviation review when needed.
• Collaborate with study teams to identify data integrity and safety risks.
• Attend trusted process meetings and participate in audits as required.

Skills

Medical data review

Data interpretation

Collaborative teamwork

Scientific communication

Job description

Syneos Health is seeking a Clinical Scientist - Oncology to collaborate with Medical Directors and study teams on medical data reviews and plans. The role focuses on data-driven decision making, rigorous interpretation of listings and visualizations, and contributing to safety assessments across oncology programs.

The position emphasizes partnership with internal and external stakeholders, adherence to ICH/GCP, and involvement in audits and process improvements to accelerate therapy delivery.